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EFFECTS OF SC..9992 IN INHIBITION OF PLATELET AGGREGATION 
N S Njcholson BB Tajte S G Penzer-Knodle A K Salyers L W Kjng 
LP Eeioen Sear1e. Skokie. IL 600n 
Pla1ele1 agoregaloon Is lmponant In rethrombosls of coronary anenes 
fol1owing 1hrombolys1s and angioplasty. SC-49992 (SC). a mime11c of lhe 
pepuoe binding sequence of k>nnogen (lgn) prevents platelel aggrega1ion 
by blocking lhe pla1ele1 g lycopn:>lein ll tvllla recep1or. In vhro, SC In· 
hiboted lgn b1nd1ng to human platelets (IC50: 6 x 10·7 M). SC Inhibited 
ADP-induced aggregahon in human pla1ele1 rich plasma (PAP) wllh an 
IC!o<l of 2 4 x 10~ Mand in dog PAP with an IC50 of 2 1 x 10·6 M. In 
washed human plalelets with thromb1n as lhe agomsl. the tC50 was 6.0 x 
1O· 7 M. In ra ts, SC blocked COiiagen Induced thrombocytopema with an 
EDso of 0 .053 mg/Kg Platelet responsrveness In the rat recovered with a 
hall hie of about 12 min. In dogs, l.V. bolus edm1nis11a1ion 1nhib11ed ex 
vrvo platelet aggregation (EDso: 0.6 mg/Kg). Dunno 2 hour infusions SC 
inh1b11ed collagen induced ex vrvo p1a1e1e1 aggregation (EDso : 7.5 
µg/Kglmin) . EuU recovery occurred 3 0 min afler 1errnina11on of a 10 
µg/kg/min infusion. 
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ADENOSlNE DIPHDSPHATE-lNDUCED PLATELET AGGREGATI ON 
AND HYPERCHOLESTEROLEHIA. D.J. Saxon. Morehead 
Sta te University, Morehead, KY 40351. 
Platelet aggregation may contribute lo the 
development of atherosc l erosis a n d thrombi. The 
purpose of the study was to d etermine if hyperchol-
esterolemia influences ADP-induced platelet aggreg-
ation. Blood from rats admini s tered a 10 week d iet 
enr i ched with 5% cholesterol + 1% sodium tauro -
chol ate were compared t o samples from ra ts on a 
normal diet. Total choles t erol, LDL, HDL and 
triglycerides were significant ly elevated (p<0.05) 
by the cho l esterol diet. Platele t counts were not 
significantl y different (p<0.05). Aggregation 
was mea sured in citrated- whole blood with Tyrode 
buffer (1: 1 ), pH 7 .4, us ing impedance aggregome try. 
Platelets from the hyperchol~sterolemic animals 
had a slightly higher relative frequency (89%) o f 
aggregation induced by 0 .5 uH of ADP compared to 
the control group (82%). The hypercholesterolemic 
pla telets had a significantly g rea ter (p<0.05) 
maximum aggregation response ( maximum impedance 
i n c rease) to 0.5 uH ADP, and also aggregated in 
response to 0.5 uH ADP at a significantly (p<0.05) 
faster rate (impedance change per second). Hyper-
c hole s t erolemia may alter the basic platelet 
reaction involving ADP-induced aggregation. 
(Supported by HSU Grant 1990-91 ) 
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lNCRE.ASED Pl.ATEL£T SENSITlVITY TO £PIN£Pl!JUl1?-l!IDUCEl> 
AGGRECATION DURINC CHRONIC STRE.SS. H. Tracv, W. Patttraon, 
D. McCla1aen, J. HArahall, and J. Patteraon (SPON: R. 
Burton). USAF School of Aeroapace Medicine, !roolt1 An, Tlt, 
and Wilford- Hall US-'F Medical C•nter, !Acltlud AFB, Tx. 
Epinephrine-induced platelet aggrega tion va1 •••eurtd in 
a group of candidattl at th• USAF Officer Training School 
(OTS) t o inveetigltt v hethtr a chronic atr1:11 a ituation 
changed t h• 1en1it i vity of platele ta to epioe pbrine-ioduced 
aggrega tion as a po1aibl e link in 1 treaa-induced athero-
scleroa ia. Subjective r1:1ponae• o! the ce1t group indicated 
that t he first t vo to three veeka of the cvelve w•ck courat 
ver• highly streooful , and that th• candidate• adapted to th• 
1ituation af t • r the third veelt. Our r e oult1 ahoved a 150% 
increase in the number o ! candida tes vhoae plate lets 
aggregated v ith e pinepbrio• during t b• ••cood veelt of ors . 
c0111pared to the number of candidatu uhibiting epinephrin•-
induced aggregation prior to b egi nning the courae. Tv•nty-
tbr .. percent of the candida t u axhibiud baulin• 
apin•phrine-inducad aggregation , v bich increa1ed to 581 at 
t he •tcond vee.k aample: . Tht ouaber of .-candidate:1 who 
uhibi ted epinephrine-induced pla telet aggregation from t he 
fourt h through th• tv•lftb veek dropped t o aa aver a ge of 
only 38%. One candidate t.Xbibited no epinephrine- induced 
aggregat i on until t h e t igh tb v aelt, vbicb coincided vith hie 
di .. i•o•l fr.,., OTS due to poor J><'tforaance. Tbeae da t a 
indicate tha t platelet ••n•itiv ity to epinephrine-induced 
aggregation incr••••• unde r etre:aa, vhicb u y reveal a 
potential link in 1tre11-1nduced athe.roacl e raais. 
SOIO 
THE INHIBITORY EFFECT OP TETRAHYOROAMINOACRIOIN"E 
ON HUKAN Pl..>.TELET FUNCTIONS. s-Y. LIV a nd ~ 
SXLVESTgR {SPON : ~) . Washington State 
univers i ty, Pull•an, WA 99163 
oral adJoinistration or 
tetrahydroam i noacridine (THAI has bee n reported to 
signi!icantly improve of the symptoms of patients 
with Al zhei•er's disease (A.O. ) . Although THA wa s 
initially used to treat A.O. because of its 
anticholineaterase a ctivity, the exact mechanism 
responsible tor the clinical e fficacy of THA is 
not clear . A.O. also produces cellular changes in 
tissues other than the CNS, i ncluding blood 
platelets. Specifically, membrane abnormalities of 
i ntracel l ular organelles o! platelets correl ates 
well wi th patient prognosis in J\ .O. I n addition , 
platelet functiona l detects may contribute to the 
progression of A.O . In this study, we determi ned 
the effect of nv. on several different act ions of 
hUB1an platelets . we f ound that THA inhibited human 
platelet a ggregation induced by various a gonists 
in a dose dependent manner. THA inhibited the 
release of platele t dense g r a nules during 
activatin a nd also, Tit.>. d ispersed platelets that 
had been a ctivated by platel et a gonists. 
Antiplatelet a ctions of Tit.>. a re dependent upon 
inhibition of intracellular ionized calcium 
mobilization. 
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Prevention of reocclusion aher 1hrombolys1s in a canine model of 
coronary occlusion. 
L P Eelaen L W King J C Campion N S Nicholson and S G Panzer· 
Kru2l1JL Searle , Skokie. II. 60077. 
SC-49992 (8 Guanid1no·Oc1anoyl· ASP·PHE) (SC) is a 
peptldomlmetic of the flbr1nogan binding &equence RGDF which btocks 
lhe platelel GPllblllla fibmogen receptor. In anestheuzed, open chest 
dogs, with 1hrombln·lnduced occlusion ol lhe LAD. etlects of hepaC1n 
(5000U). aspirin (10 mg/kg) and SC (10·80 µg/kgtmln 1v) were 
evalua1ed on lysls end reoccluslon following repeated 1v ln1ec1lons of 
!PA. Vessel patency was del&fmlned with an elec1romagne1ic 
flowma1er. Heparin alone (5000 U) had a s1gnll1can1, bul llmlted. 
eHect reducing lime to lys1s from 45 :t 10 min 10 21 : 3 min. 
Reocciusion time was no1 Changed. AU subsequent studies were done In 
the presence of heparin, and heparin data were taken 10 be control. 
Aspirin (1 O mg/Kg) had no ellect on 11me to lys1s bul prolonged the 
time 10 reocclusion from 3 .4 t0.6 10 29 ± 1 O min. SC completely 
prevenled reocciusion al doses > 30 µglkglmin. Al a dose ol 80 
µo/kglmin, It also significanlly shOnened 1he time 10 lys1s from 21 ± 
3 10 7.4 ± t .4 min. When platelel aggregalion was inhibited >50% 1n 
dog plalelets ex-vivo (30 µglkglmin In lhls model). template bleeding 
hmes exceeded 30 min. SC has a shon pharmacodynamic hall Ille (• 
1 o min), suggesling lhal H bleeding were 10 become a problem, platelet 
function would be restored rapidly aher administration ol 1he compound 
were terminated. 
3084 
CORRELATION OF VERY RAPID PLATELET ADHESION TO COUAGEN 
WITH PLATELET DENSrN AND SIZE. Ben8la Polaoowske-Orabow$ka, 
Saoghembra Boho and M r1on A.L Gear. Dept. Blochemlsuy, Unrv. of 
Vlrglnlo, Char1otteavtlle, VA 22908. 
We ha•• previously atlOWT'l lhal 9dhealon of human platelets to 
lmmobllized oollagen 18 extr9m&ly rapid, with lnJtlaJ rates approaching 
300'l' of &Ingle ~ lldll9r1ng I* HCO!ld. Here, - have Investigated 
adhealon etrlclency u a tunctlon of platelet dena/ty. Platelet 
aut>popui.tlonl were Mparated by Percoll denshy11radlent oentrifugabon 
Into llvee lractlona; Nght (1 .040<e<1 .065 g/mQ. Intermediate 
(1.065<e < 1.070 g/mQ and heavy (1.070< e <1.080 g/mQ, which const!Med 
20, 60 and 30% of the total platelet population, having mean volumes of 
5.45, 6.27 and 7.25 n. respectively. Using a continouous-ftow, mic:to· 
all\nl1y column, we lound Iha! the denseSl (largest) platelal5 adhered to 
collagen ~ and 1.5 Umes laster than the Ught and Intermediate populalions. 
They _,. also leu Mnaltlve to Inhibition by PG'7- In contrast, there was 
no dJ11erenoe In ADP °' oollagetHnduced aggreoa!lon between Ugh! and 
heavy lractlonl, lndlc:aUng Iha! heavy platelets -e not preferentially 
Involved In collagen-Induced aggregation. 1hese results auggeS1 lhal 
nonnaJ c:Uculatlng platelets are d isUnctly heterogenous In their ability to 
adhere to collagen under arter1al-llow conditions. The greater efficiency of 
heavy platelets fTl*Y be related to an Increased content °' dl!ferent types of 
collagen reoeptort oompared to the lighter platelets. It ls not a reftectlon 
ol varylng platelet number, alnoe adhesion effid oncy Is not allected by 




ADENOSINE DIPHOSPHATE (ADP) IS AN AGONIST FOR 
PLATELET AGGREGATION. ERYTHROCYTES AND 
' ENDOTHELIAL CELLS MAY BE THE SOURCES OF ADP 
' AS AN AGONIST FOR PLATELET AGGREGATlqN. 
PLATELET ACTIVATION BY A VARIETY OF AGONIS'fS 
' INDUCES ADP RELEASE FROM THE DENSE GRANULES 
OF PLATELETS AS A PART OF A POSITIVE FEEDBACK 
LOOP FOR IRREVERSIBLE AGGREGATION. ADP AT 
CONCENTRATIONS =I< 0.5 µM PRODUCES 
REVERSIBLE PLATELET AGGREGATION. WITH ADP 
CONCENTRATIONS OF 2 - 5 µM IRREVERSIBLE 
AGGREGATION OCCURS WITH SECRETION OF 
PLATELET CONSTITUTENTS FROM a GRANULES 
(ADHESIVE PROTEINS, PLATELET-DERIVED GROWTH 
FACTOR, TRANSFORMING GROWTH FACTOR}&, 
PLATELET FACTOR, THROMBOGLOBULIN) AND DENSE 
. I 
GRANULES (ADP, ATP, CA++, SEROTONIN). ~ 
I 
REVERSIBLE PLATELET AGGREGATION MAY BE 
RELATED TO THE PHYSl'OLOGICAL FUNCTION OF 
I 
REPAIRING ENDOTHELIUM AND SECRETION OF 
GROWTH FACTORS FROM a GRANULES. TME 
IRREVERSIBLE RESPONSE IS INVOLVED IN THE 
HEMOSTATIC FUNCTION OF PLATELETS. 1 
HYPERCHOLESTEROLEMIA AND OXIDIZED LqW 
DENSITY LIPOPROTEIN (LDL) ARE REPORTED TO HAVE 
I 
A PROMINENT ROLE IN INJURY "fO MANY CELL TYPES 
AND TO OCCUPY A SIGNIFICANT ROLE /IN 
ATHEROSCLEROSIS. 
PLATELETS IN WHOLE BLOOD ARE CERTAINLY 
EXPOSED TO A MULTITUDE OF MOLECULES, 
' ' 
INCLUDING OXIDIZED LDL AND AGONISTS FOR 
I 
AGGREGATION LIKE ADP FROM ERYTHROCYTES AND 
ENDOTHELIAL CELLS. IMPEDANCE AGGREGOMET~Y 
PERMITS THE UTILIZATION OF WHOLE BLOOD 
TO MEASURE THIS PLATELET FUNCTION. . 1 
THEREFORE THE OBJECTIVE OF THIS STUDY WAS TO . I 
DETERMINE IF HYPERCHOLESTEROLEMIA ALTERS THE 
I 
RESPONSE OF PLATELETS TO ADP-INDUCED 
I 
AGGREGATION AS MEASURED IN WHOLE BLOOD ~y 
IMPEDANCE AGGREGOMETRY. I 
I 
--- METHODS 
--------- DIETARY-GROUPs--oF-MAlE SPRAGUE-DAW-LE¥-RATS--l275,,-299_GBAMS): 
1. NORMAL DIET: PURINA 5001 LABORATORY RODENT 
CHOW FOR 10 WEEKS 
2. HIGH CHOLESTEROL DIET: RODENT CHOW ENRl.CHED WITH 
5°/o CHOLESTEROL + 1 % SODIUM 
T AUROCHOLATE (BIOS ERV) 
FOR 10 WEEKS 
BLOOD SAMPLES: 
TAIL ARTERIAL BLOOD + 3.2% SODIUM CITRATE (9:1 RATIO) 
PLATELET COUNTS: 
PLATELET COUNTS OF PLATELET-RICH PLASMA WERE DETERMINED WITH 
A COULTER ZF COUNTER 
______ DETERMINATION OF PLASMA LIPID LEVELS: ______________________ _ 
1. TOTAL CHOLESTEROL: MODIFICATION OF ALLAIN ET AL PROCEDURE 
(1974) SIGMA DIAGNOSTICS PROCEDURE 
N0.352 
2. TRIGLYCERIDES: MODIFICATION OF MCGOWAN ET AL· 
PROCEDURE (1983) SIGMA 
DIAGNOSTICS PROCEDURE NO. 339 
3. HDL-CHOLESTEROL: WARNER ET AL PROCEDURE (1982) 
SIGMA DIAGNOSTICS PROCEDURE 
NO. 352-3 
4. LDL-CHOLESTEROL: CALCULATION BASED ON FRIEDEWALD 
ET AL (1972) 
MEASUREMENT. OF ADP-INDUCED_ P_L~TELET _A_G~_REGATlq!'f _ l!'f WHOLE 
BLOOD: -- ----------- -----
1. BLOOD SAMPLES WERE PREPARED IN A 1 :1 RATIO (0.5 ML + 0.5 ML) 
OF CITRATED BLOOD AND TYRODE SOLUTION CONTAINING ALBUMIN, 
pH 7.4. 
2. 0.5 MICROMOLAR CONCENTRATION OF ADP PER FINAL VOLUME IN 
EACH AGGREGATION CUVETTE WAS USED. 
3. MEASUREMENT OF PLATELET AGGREGATION WAS PERFORMED IN A 
CHRONO-LOG MODEL 530 WHOLE BLOOD AGGREGOMETER. 
ANALYSIS OF DATA: 
POOLED t-TESTS WERE USED TO COMPARE LIPID LEVELS, PLATJ:LET 
COUNTS, MAXIMAL IMPEDANCE RESPONSES, AND RATE OF IMPEDANCE 
RESPONSES BETW~EN THE CONTROL· AND EXPERIMENTAL GROUPS. 
RESULTS 
--- - --- -- - --- - - --- -- -- -- ---~- -- - - - - ----- - ----- ----- ------
PLASMA LIPID LEVELS WERE SIGNIFICANTLY ALTERED BY THE HIGH 
CHOLESTEROL DIET. TOT AL CHOLESTEROL, LDL-CHOLESTEROL, AND 
TRIGLYCERIDES WERE SIGNIFICANTLY ELEVATED, WHILE HDL-. . 
CHOLESTEROL WAS SIGNIFICANTLY DECREASED (TABLE 1). 
THERE WAS NO SIGNIFICANT DIFFERENCE IN PLATELET COUNTS OF RATS 
RECEIVING THE NORMAL DIET AND HIGH CHOLESTEROL DIET (TABLE 2). 
PLATELETS FROM HYPERCHOLESTEROLEMlC RATS AGGREGATED IN 
RESPONSE TO 0.5 µM ADP AT A SLIGHTLY HIGHER FREQUENCY THAN 
PLATELETS FROM NORMOCHOLESTEROLEMIC RATS (TABLE 3). 
FIGURE 1 ILLUSTRATES TYPICAL ADP-INDUCED PLATELET 
AGGREGATION RESPONSES TO 0.5 µM ADP FOR NORMOCHOLESTEROLEMIC 
PLATELETS AND HYPERCHOLESTERO·LEMIC PLATELETS. THE 
AGGREGATION RESPONSES TO 0.5 µM ADP BY PJ_ATELETS FROM 
HYPERCHOLESTEROLEMIC RATS WERE SIGNIFICANTLY GREATER THAN 
PLATELET AGGREGATION RESPONSES FROM NORMOCHOLESTEROLEMIC 
RATS IN REGARD TO BOTH MAXIMUM CHANGE IN IMPEDANCE AND RATE 
OF CHANGE IN IMPEDANCE (TABLE 4). . 
-
TABLE 1: PLASMA LIPID LEVELS OF RATS FED FOR 10 WEEKS ON 
A NORMAL DIET OR A HIGH CHOLESTEROL DIET CONTAINING 
5% CHOLESTEROL AND 1% SODIUM TAUROCHOLATE --- ----- ---- --- ___ ... ______ ---- -- - - ------------------ ----- --- --- ------
Plasma 
lipid 
N Diet Rats 
n mg 0&> 
HC Diet Rats 
TC 1 1 76.7 +/- 18.7 
LDL 11 . 5.6 +/- 4.9 
HDL 10 55.9 +/- 14.0 
TG 1 1 78.0 +I- 27 .5 
mg% as mean, +I- standard deviation 
n = number of animals 
n mg% 
10 300.7 +/- 94.0 
8 230.9 + /- 98.3 
7 40.1 + /- 11 .3 
10 105.5 +/- 27.7 
N = normal diet, HC . high cholesterol diet 
TC = total cholesterol, LDL = LDL cholesterol 
HDL = HDL cholesterol, TG = triglycerides 






TABLE 2: PLATELET COUNTS OF RATS FED FOR 10 WEEKS ON A NORMAL 
---- ----- -- ----DIET-oR--A-HIGH-CHOtESTEROL-Dle'f-CONTAINING-- --- -------
. . 







Platelet Counts in Millions 
Per ml of Whole Blood 
105.6 + /- 5.4 
102.0 +I- 6.3 
N = normal diet, HC = high cholesterol diet 
n = number of animals 
Platelet counts as mean + /- standard deviation 
NS = not significant at p < .005 
t-test · 
NS 
TABLE 3: RELATIVE FREQUENCIES OF PLATELET AGGREGATION 
-------~- ---- FOttOWING-ADDITION-oF-0~5-MICR-Ol\7rOLAR-ADENO-SINE _________ ---
DI PHOSPHATE TO BLOOD FROM RATS FED FOR 10 
WEEKS ON A NORMAL DIET OR A 5% CHOLESTEROL AND 
1% SODIUIVI TAUROCHOLATE DIET 
Diet Group n Frequency of Aggregation Percentage 
N 11 9 81.8 
HC 9 8 88.8 
N = normal diet 
HC = high cholesterol diet 
n = number of animals 
- -
TABLE 4: ADENOSINE DIPHOSPHATE-INDUCED PLATELET AGGREGATION 
FOLLOWING ADDITION OF 0.5 MICROMOLAR ADP TO BLOOD 
------- . __ EBQM~_RAT_S_FEQ __ EQB_1_Q_WEEKS__QJ~ __ A N_QBMAl_O_lET OR ~A~ 
5% CHOLESTEROL AND 1 % SODIUM TAUROCHOLATE DIET 
Diet Group n Delta Ohms/Sec Maximum Delta Ohms 
N 9 0.077 + /- .034 8.00 +/- 5.28 
HC 7 0.213 +/- .103 15.53 +/- 8.55 
t-test p < .001 p < .001 
N = normal diet 
HC = high cholesterol diet 
Delta Ohms/Sec as mean + /- standard deviation 
Maximum Delta Ohms as mean + /- standard deviation 
~~p ADDITION 
--- ______ ., 
-- --- -- -- - - ------·--·-----·-- - - --------------- --























FIGURE 1: TYPICAL AGGREGATION RESPONSES TO 0.5 µM ADP BY 
PLATELETS IN 0.5 ML CITRATED BLOOD+ 0.5 ML 
TYRODE BUFFER, pH 7 .4. N = NORMOCHOLESTEROLEMIC 
~LOOD, HC = HYPERCHOLESTEROLEMIC BLOOD. 
CONCLUSIONS 
HYPERCHOLEST_ERQLEMIA_D_O_ES_APPEAR.-IO-l:IAVE-A-ROLE--IN--AL+ERING----
-- THE PLATELET RESPONSE OF ADP-INDUCED AGGREGATION AS MEASURED 
IN WHOLE BLOOD USING IMPEDANCE AGGREGOMETRY. 
THE ALTERATIONS IN PLATELET RESPONSE TO 0.5 µM ADP INCLUDE: 
1. A SIGNIFICANTLY GREATER MAXIMUM AGGREGATION RESPONSE BY 
PLATELETS OF HYPERCHOLESTEROLEMIC RATS AND 
2. A SIGNIFICANTLY GREATER RATE OF AGGREGATION BY THESE 
THESE HYPERCHOLESTEROLEMIC PLATELETS. 
THESE ALTERATIONS BY HYPERCHOLESTEROLEMIA IN REGARD TO 
PLATELET RESPONSES TO ADP ARE IMPORTANT SINCE ADP 
DERIVED FROM ERYTHROCYTES AND ENDOTHELIAL CELLS 
MAY BE AN AGONIST FOR PLATELET AGGREGATION AND BECAUSE ADP IS 
ALSO RELEASED FROM DENSE GRANULES AS A PART OF A POSITIVE 
FEEDBACK LOOP IN THE BASIC PLATELET REACTION TO A VARIETY 
OF AGONISTS. 
